Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiry date, which is stated on the label, carton and blister after the letters EXP. The expiry date refers to the last day of that month.
If your medicine is packaged in Aluminum/Aluminum blisters:
Store in the original carton to protect from moisture.
If your medicine is packaged in PVDC blisters:
Do not store above 25 ºC. Store in the original carton to protect from moisture
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. Contents of the pack and other information
What Galantagen Retard contains:
The active substance is galantamine
- Galantagen Retard 8 mg hard prolonged release capsules contains 8 mg galantamine (as hydrobromide).
- Galantagen Retard 16 mg hard prolonged release capsules contains 16 mg galantamine (as hydrobromide).
- Galantagen Retard 24 mg hard prolonged release capsules contains 24 mg galantamine (as hydrobromide).
Page 6 of 8
The other ingredients are:
Tablet core (Contents of the capsule): Polyvinyl acetate, silica colloidal anhydrous, povidone, hydrogenated vegetable oil, sodium lauryl sulphate and magnesium stearate.
Capsule Shell:
Gelatin, titanium dioxide (E171), Allura Red AC (E129)
Printing Ink: Shellac, propylene glycol, potassium hydroxide, black iron oxide (E172).
What Galantagen Retard looks like and contents of the pack
Galantagen Retard is available in three strengths, each of which can be recognised by its lettering:
Galantagen Retard 8 mg hard prolonged release capsules are hard gelatin capsules with a white body and pink cap, printed in black ink ‘MYLAN’ over ‘GT8’ on the body and the cap.
Galantagen Retard 16 mg hard prolonged release capsules are hard gelatin capsules with a white body and pink cap, printed in black ink ‘MYLAN’ over ‘GT16’on the body and the cap.
Galantagen Retard 24 mg hard prolonged release capsules are hard gelatin capsules with a white body and pink cap, printed in black ink ‘MYLAN’ over ‘GT24’ on the body and the cap.
The 8 mg, 16 mg and 24 mg are available in:
- PVDC blisters containing 7, 10, 28, 30, 56, 84, 98, or 100 capsules
- Aluminum/Aluminum blisters containing 7, 10, 28, 30, 56, 84, 98, or 100 capsules
Not all pack sizes may be marketed.
Dit geneesmiddel is ingeschreven in het register onder nummer:
RVG 107655 - Galantagen Retard 8 mg
RVG 107656 -Galantagen Retard 16 mg
RVG 107657 -Galantagen Retard 24 mg
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Mylan B.V.
Dieselweg 25
3752 LB Bunschoten
Manufacturer
McDermott Laboratories Limited trading as Gerard Laboratories, 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13,Ireland
Generics [UK ] Ltd. Station Close, Potters Bar, Hertfordshire, EN6 1TL United Kingdom
This medicinal product is authorised in the Member States of the EEA under the following names:
NL/H/2053/001-003
Page 7 of 8
Member State | Medicinal Product Name |
Italy | Galantamina Mylan 8mg, 16mg and |
| 24mg |
The Netherlands | Galantagen Retard 8mg, 16mg, 24mg, |
| capsules met verlengde afgifte, hard |
This leaflet was last approved in augustus 2013.
Page 8 of 8